1. Beck W, Grogan T, Willman C, Cordon-Cardo C, Parham D, Kuttesch J, Andreeff M, Bates S, Berard C, Boyett J, Brophy N, Broxterman H, Chan H, Dalton W, Dietel M, Fojo A, Gascoyne R, Head D, Houghton P, Srivastava D, Lehnert M, Leith C, Paietta E, Pavelic Z, Rimsza L, Ronnson I, Sikic B, Twentyman P, Warnke R, Weinstein R: Methods to detect P-glycoprotein-associated multidrug resistance in patients’ tumors: consensus recommendations. Cancer Research 1996, 56:3010–3020.
2. Marie J, Huet S, Faussat A, Perrot J, Chevillard S, Barbu V, Bayle C, Boutonnat J, Calvo F, Campos-Guyotat L, Colosetti P, Cazin J, P dC, Delvincourt C, Demur C, Drenou B, Fenneteau O, Feuillard J, Garnier-Suillerot A, Genne P, Gorisse M, Gosselin P, Jouault H, Lacave R, Le Calvez G, Léglise M, Léonce S, Manfait M, Maynadié M, Merle-Béral H, Merlin J, Mousseau M, Morjani H, Picard F, Pinguet F, Poncelet P, Racadot E, Raphael M, Richard B, Rossi J, Schlegel N, Vielh P, Zhou D, Robert J: Multicentric evaluation of the MDR phenotype in leukemia. Leukemia 1997, 11:1086–1094.
3. Beck J, Handgretinger R, Dopfer R, Klingebiel T, Niethammer D, Gekeler V: Expression of mdr1,mrp,topoisomerase IIa/b and cyclin A in primary or relapsed states of acute lymphoblastic leukemia. British Journal of Haematology 1995, 89:356–363.
4. Kuwazuru Y, Hanada S, Furukawa T, Yochimura A, Sumizawa T, Utsunomiya A, Ishibashi K, Saito T, Uozumi K, Maruyama M, Ishizawai M, Arima T, Akiyama S: Expression of P-glycoprotein in adult T-cell leukemia cells. Blood 1990, 10:2065–2071.
5. Hunault M, Zhou D, Delmer A, Ramond S, Viguié F, Cadiou M, Perrot J, Levy V, Rio B, Cymbalista F, Zittoun R, Marie J: Multidrug resistance (MDR1) gene expression in acute myeloid leukemia: major prognosis significance for the in vivo drug resistance to induction treatment. Annals of Hematology 1997, 74:65–71.